Allegro receives US patent for integrin peptide therapy Luminate

Allegro announced a U.S. patent was issued for Luminate for “composition of matter” and “methods of use in the treatment of various ophthalmic disorders, neovascular conditions and tumors.”This is the first U.S. patent Allegro has received, the announcement said.